The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

ProShares Ultra Nasdaq Biotechnology

Nasdaq: BIB
Last

(U.S.) $126.88

Today's change+3.34 +2.70%
Updated November 26 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

ProShares Ultra Nasdaq Biotechnology

Nasdaq: BIB
Last

(U.S.) $126.88

Today's change+3.34 +2.70%
Updated November 26 4:00 PM -5GMT. Delayed by at least 15 minutes.

ProShares Ultra Nasdaq Biotechnology Hits New 52-week High

ProShares Ultra Nasdaq Biotechnology closed up sharply Wednesday, rallying (U.S.)$3.34 or 2.70% to (U.S.)$126.88 and setting a new 52-week high. Over the last five days, shares have gained 6.67% and 68.62% year to date. Shares have outperformed the S&P 500 by 59.63% during the last year.

Key company metrics

  • Open(U.S.) $123.97
  • Previous close(U.S.) $123.54
  • High(U.S.) $126.89
  • Low(U.S.) $123.40
  • Bid / Ask-- / --
  • YTD % change+68.62%
  • Volume149,096
  • Average volume (10-day)189,565
  • Average volume (1-month)242,907
  • Average volume (3-month)251,982
  • 52-week range(U.S.) $60.89 to (U.S.) $126.89
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS--
Updated November 26 4:00 PM -5GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow